Rocket Pharmaceuticals, Inc. (RCKT) vs X4 Pharmaceuticals, Inc. (XFOR)
Rocket Pharmaceuticals, Inc. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Rocket Pharmaceuticals, Inc. and X4 Pharmaceuticals, Inc. are of similar size ($300.8M and $297.4M). Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −568.8%) and the higher return on invested capital (−114.7% vs −226.6%). Across the 14 metrics below, Rocket Pharmaceuticals, Inc. leads on 10 and X4 Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | RCKT | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 81.51% | 65.16% |
| Operating margin | 0.00% | (554.71%) | 0.00% |
| Net margin | 0.00% | (568.80%) | 0.00% |
| Free cash flow margin | 0.00% | (559.95%) | 0.00% |
| Return on equity | (4.77%) | (113.08%) | (57.72%) |
| Return on assets | (4.09%) | (50.32%) | (49.22%) |
| Return on invested capital | (114.71%) | (226.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack